Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Kenneth B. McCredie"'
Autor:
Kenneth B. McCredie, G. Spitzer, Dharmvir S. Verma, Axel R. Zander, Dennis A. Johnston, Miloslav Beran
Publikováno v:
Scandinavian Journal of Haematology. 28:254-263
To investigate the source and the mechanisms of synergistically enhanced colony-stimulating activity elaboration by the coincubated monocyte-macrophages and T lymphocytes, we simultaneously prepared conditioned media both from the coincubated monocyt
Autor:
Alfred Paul Mulzet, Victor R. Kruger, Kenneth B. McCredie, Emil J Freireich, Robert Melroy Kellogg, Jeane P. Hester
Publikováno v:
Therapeutic Apheresis. 4:98-107
Guest Editor's Introduction: By 1977, the NCI/IBM 2990 and the Amico Celltrifuge, a conceptually similar instrument that had an identical centrifuge bowl, were being used worldwide. However, a major technical problem remained in that the blood path w
Autor:
Kenneth B. McCredie, Cheryl F Hirsch-Ginsberg, Michael J. Keating, M. Beran, Razelle Kurzrock, Yang O. Huh, Eli Estey, Charles Koller, Hagop M. Kantarjian, Susan O'Brien
Publikováno v:
Blood. 79:882-887
We administered one course of 2-chlorodeoxyadenosine (2CdA) at 4 mg/m2 daily for 7 days by continuous intravenous infusion to 46 patients with hairy cell leukemia. Complete remissions occurred in 36 patients (78%; 95% confidence limits, 63% to 89%),
Autor:
Hagop M. Kantarjian, Elihu H. Estey, Kenneth B. McCredie, Susan O'Brien, Emil J. Freireich, Miloslav Beran, Jordan U. Gutterman, Moshe Talpaz, Michael J. Keating
Publikováno v:
Cancer. 68:1201-1207
In a pilot study, 32 patients with Philadelphia chromosome-positive chronic myelogenous leukemia were treated with intensive chemotherapy induction followed by interferon-alpha (IFN-A) maintenance. Intensive chemotherapy consisted of three cycles of
Autor:
Miloslav Beran, Michael J. Keating, Elihu H. Estey, Charles Koller, Kantarjian Hagop, Susan O'Brien, Kenneth B. McCredie
Publikováno v:
Cancer. 68:691-694
Among 35 patients with relapsed or refractory acute myelogenous leukemia (AML) who received salvage chemotherapy, 28 were treated with mitoxantrone (7.5 mg/m2/d intravenously [IV] over 1 hour for 5 days) and etoposide (VP-16) (2 g/m2 over 4 days eith
Publikováno v:
American Journal of Hematology. 37:88-99
We have studied the cytotoxic profile and distribution of lymphocyte subsets of patients with acute myelogenous leukemia in second remission, after continuous infusion with recombinant interleukin-2 (IL-2). The patients received repetitive cycles of
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology. 71:45-49
This study was designed to elicit the effects of antileukemia chemotherapy on marrow production, blood carriage, and oral extravasation of granulocytes, and on the phagocytic activity of those harvested from the mouth. Fifteen adult patients with var
Autor:
Emil J. Freireich, K. Totpal, Kenneth B. McCredie, C. A. Savary, J. Schachner, B. Lichtiger, Eva Lotzová
Publikováno v:
Leukemia Research. 15:245-254
We have generated and characterized a highly oncolytic adherent lymphocyte subset (A-LAK) from eight leukemic patients with non-lymphocytic leukemia (NLL) in remission and one NLL patient in relapse. Our studies demonstrated that A-LAK was superior i
Autor:
Kenneth B. McCredie, Charles Koller, Moshe Talpaz, Hagop M. Kantarjian, Michael J. Keating, Jay Schachner, Susan O'Brien, Craig C. Childs, Emil J. Freireich
Publikováno v:
Journal of Clinical Oncology. 9:44-49
Thirty-three patients with chronic lymphocytic leukemia (CLL) with advanced Rai stage (III-IV) or progressive Rai stage (0-II) disease were treated with fludarabine as a single agent. Eleven patients (33%) obtained a complete remission (CR), 13 (39%)
Autor:
Hagop M. Kantarjian, Elihu H. Estey, Sundar Jagannath, Michael J. Keating, L. J. Horwitz, Jorge A. Spinolo, Kenneth B. McCredie, Karel A. Dicke, Gary Spitzer, Zander Ar
Publikováno v:
Cancer. 66:619-626
The authors administered high-dose chemotherapy with cyclophosphamide, BCNU (carmustine) and VP-16 (etoposide) plus autologous bone marrow transplantation (ABMT) to 22 adult patients with relapsed acute leukemia in second or subsequent remission. The